ATG biosynthetics GmbH - Company Review
ATG biosynthetics GmbH - Company ReviewSummary
ATG:biosynthetics GmbH (ATG) is a biotechnology company that offers gene synthesis, gene optimization and expression systems for synthetic bioinformatics. The company provides acceptor-donor plasmid systems, vector assembly system, and toggle plasmid system. It also offers multi-gene and multi-peptide expression products and services in the fields of drug discovery, industrial and medical biotechnology, molecular diagnostics, and bioengineering. ATG provides DNA optimization and cluster design services. The company has partnership with other medical device and biotechnology companies. It operates in Germany, Austria, France, the UK, and the US. ATG is headquartered in Merzhausen, Germany.
This comprehensive company report of ATG biosynthetics GmbH provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.